Wednesday, July 25, 2018 5:16:36 PM
Recent SMTI News
- Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates • GlobeNewswire Inc. • 04/29/2024 01:15:00 PM
- Sanara MedTech Inc. Announces $55 Million Debt Facility • GlobeNewswire Inc. • 04/18/2024 01:15:00 PM
- Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer • GlobeNewswire Inc. • 04/05/2024 01:00:00 PM
- Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 03/25/2024 08:05:00 PM
- Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates • GlobeNewswire Inc. • 03/13/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:05:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 08:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:20:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 11:18:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:01:46 PM
- Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023 • GlobeNewswire Inc. • 02/22/2024 02:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:29:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/05/2024 11:27:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:05:58 PM
- Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides • GlobeNewswire Inc. • 01/03/2024 02:15:00 PM
- Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing • GlobeNewswire Inc. • 11/30/2023 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:42:17 PM
- Sanara MedTech Inc. Announces Third Quarter 2023 Results • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:02:43 PM
- Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates • GlobeNewswire Inc. • 10/30/2023 01:15:00 PM
- Sanara MedTech Announces First Sale of ALLOCYTE® Plus Advanced Viable Bone Matrix and Provides Other Product Updates • GlobeNewswire Inc. • 10/10/2023 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/22/2023 08:05:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2023 12:00:44 PM
- Sanara MedTech to Participate in Two Upcoming Conferences • GlobeNewswire Inc. • 09/12/2023 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2023 10:02:46 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM